EGFR and triple-negative breast carcinoma: Epidermal growth factor receptor, EGFR (HER1), over-expressed in triple negative breast cancers [49], was down-regulated in MDA-MB-231 cells by NP109 in the dose response (Figure 3e) and time course (Figure 3f) studies.